Ovid Therapeutics Inc.OVIDNASDAQ
Loading
Gross Margin Over TimeStrong
Percentile Rank55
3Y CAGR-1.4%
5Y CAGR-0.8%
Studio
Year-over-Year Change

Gross profit as a percentage of revenue

3Y CAGR
-1.4%/yr
Annual compound
5Y CAGR
-0.8%/yr
Consistent
Percentile
P55
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM95.86%-4.1%
2024100.00%0.0%
2023100.00%0.0%
2022100.00%0.0%
2021100.00%0.0%
2020100.00%-
20190.00%-
20180.00%-
20170.00%-
20160.00%-